Stay updated on Pembrolizumab/Vibostolimab Combo in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab/Vibostolimab Combo in NSCLC Clinical Trial page.

Latest updates to the Pembrolizumab/Vibostolimab Combo in NSCLC Clinical Trial page
- CheckyesterdayChange DetectedThe page has been updated to version 2.16.5, and the previous version 2.16.4 has been removed from the content.SummaryDifference0.7%
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.5%
- Check22 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.0%
- Check30 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.0%
- Check37 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference0.8%
- Check44 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.1%
Stay in the know with updates to Pembrolizumab/Vibostolimab Combo in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab/Vibostolimab Combo in NSCLC Clinical Trial page.